Cutler Group LP Apellis Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$55.39 - $72.47 $803,155 - $1.05 Million	-14,500 Reduced 59.92%	9,700 $55,000
Q4 2023 Jan 18, 2024	SELL	$37.14 - $64.82 $999,066 - $1.74 Million	-26,900 Reduced 52.64%	24,200 $261,000
Q3 2023 Nov 07, 2023	BUY	$23.65 - $89.22 $986,204 - $3.72 Million	41,700 Added 443.62%	51,100 $31,000
Q2 2023 Jul 18, 2023	BUY	$76.68 - $93.31 $176,364 - $214,613	2,300 Added 32.39%	9,400 $167,000
Q1 2023 May 01, 2023	SELL	$46.59 - $66.96 $2.46 Million - $3.53 Million	-52,700 Reduced 88.13%	7,100 $62,000
Q4 2022 Feb 07, 2023	BUY	$43.24 - $61.04 $345,920 - $488,320	8,000 Added 15.44%	59,800 $258,000
Q3 2022 Oct 25, 2022	BUY	$44.76 - $69.66 $505,788 - $787,158	11,300 Added 27.9%	51,800 $931,000
Q2 2022 Aug 04, 2022	SELL	$35.07 - $59.21 $505,008 - $852,624	-14,400 Reduced 26.23%	40,500 $26,000
Q1 2022 Apr 14, 2022	BUY	$35.46 - $54.12 $1.71 Million - $2.61 Million	48,300 Added 731.82%	54,900 $351,000
Q4 2021 Jan 18, 2022	SELL	$30.74 - $49.16 $1.99 Million - $3.18 Million	-64,600 Reduced 90.73%	6,600 $49,000
Q3 2021 Oct 26, 2021	BUY	$31.4 - $69.84 $1.79 Million - $3.97 Million	56,900 Added 397.9%	71,200 $33,000
Q2 2021 Jul 19, 2021	BUY	$40.9 - $64.9 $482,620 - $765,820	11,800 Added 472.0%	14,300 $205,000
Q1 2021 Apr 26, 2021	BUY	$40.8 - $57.39 $81,600 - $114,780	2,000 Added 400.0%	2,500 $6,000
Q4 2020 Jan 21, 2021	SELL	$30.79 - $57.2 $58,501 - $108,680	-1,900 Reduced 79.17%	500 $6,000
Q3 2020 Oct 27, 2020	BUY	$25.89 - $33.65 $25,890 - $33,650	1,000 Added 71.43%	2,400 $4,000
Q2 2020 Jul 22, 2020	SELL	$24.8 - $38.49 $19,840 - $30,792	-800 Reduced 36.36%	1,400 $4,000
Q1 2020 May 07, 2020	SELL	$17.91 - $44.33 $259,695 - $642,785	-14,500 Reduced 86.83%	2,200 $3,000
Q4 2019 Feb 06, 2020	BUY	$22.1 - $30.8 $327,080 - $455,840	14,800 Added 778.95%	16,700 $86,000
Q3 2019 Oct 28, 2019	BUY	$24.09 - $32.18 $45,771 - $61,142	1,900 New	1,900 $7,000

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

Wellington Management Group LLP Boston, MA

15.6M
Shares

$516 Million
0.08% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.9M
Shares

$394 Million
14.88% of portfolio
Avoro Capital Advisors LLC New York, NY

11.1M
Shares

$368 Million
4.82% of portfolio
Vanguard Group Inc Valley Forge, PA

9.82M
Shares

$325 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.8M
Shares

$192 Million
0.01% of portfolio

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account